BlossomHill Therapeutics, Inc. (BLSM)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 5 signals for BlossomHill Therapeutics, Inc.. Most notable: 2026-08-10: 4 insiders bought $25.1M within 14 days; 2026-08-10: GORDON CARL L (director) bought $10.0M of stock; 2026-08-10: ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC (director) bought $10.0M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Insider buying cluster4 insiders bought $25.1M within 14 days
- Insider purchaseORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC (director) bought $10.0M of stock
- Insider purchaseGORDON CARL L (director) bought $10.0M of stock
- Insider purchaseChen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund V LP; Cormorant Private Healthcare Fund VI, LP (director) bought $5.0M of stock
- Insider purchaseSchmid John P. (director) bought $96k of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-10 | GORDON CARL L | director | C | 1,039,996 | — | — |
| 2026-08-10 | GORDON CARL L | director | C | 1,049,283 | — | — |
| 2026-08-10 | GORDON CARL L | director | P | 625,000 | 16 | $10,000,000 |
| 2026-08-10 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC | director | C | 1,039,996 | — | — |
| 2026-08-10 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC | director | C | 1,049,283 | — | — |
| 2026-08-10 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VIII LLC | director | P | 625,000 | 16 | $10,000,000 |
| 2026-08-10 | Schmid John P. | director | P | 6,000 | 16 | $96,000 |
| 2026-08-10 | Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund V LP; Cormorant Private Healthcare Fund VI, LP | director | C | 1,599,993 | — | — |
| 2026-08-10 | Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund V LP; Cormorant Private Healthcare Fund VI, LP | director | C | 1,701,541 | — | — |
| 2026-08-10 | Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund V LP; Cormorant Private Healthcare Fund VI, LP | director | P | 312,500 | 16 | $5,000,000 |
| 2026-08-10 | Agrawal Sundeep | director | C | 578,524 | — | — |
| 2026-08-10 | Keyes Jason A | officer | P | 700 | 16 | $11,200 |
| 2026-08-10 | Liptak Vincent Paul | officer | P | 2,200 | 16 | $35,200 |
| 2026-08-10 | Liptak Vincent Paul | officer | C | 22,687 | — | — |
| 2026-08-10 | Li Yishan | director | C | 1,600,682 | — | — |
| 2026-08-10 | Li Yishan | director | C | 113,435 | — | — |
| 2026-08-10 | Li Yishan | director | C | 124,779 | — | — |
| 2026-08-10 | Cui Jingrong Jean | director | C | 1,600,682 | — | — |
| 2026-08-10 | Cui Jingrong Jean | director | C | 113,435 | — | — |
| 2026-08-10 | Cui Jingrong Jean | director | C | 124,779 | — | — |
| 2026-08-07 | Liptak Vincent Paul | officer | P | 2,500 | 15.8 | $39,500 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-18 8-K
- 2026-09-18 10-Q
- 2026-09-15 8-K
- 2026-08-18 SCHEDULE 13D
- 2026-08-17 SCHEDULE 13G
- 2026-08-14 SCHEDULE 13G
- 2026-08-13 SCHEDULE 13D
- 2026-08-12 4
- 2026-08-12 4
- 2026-08-10 4
- 2026-08-10 4
- 2026-08-10 4
- 2026-08-10 4
- 2026-08-10 4
- 2026-08-10 4
- 2026-08-10 4
- 2026-08-10 4
- 2026-08-10 4
- 2026-08-10 S-8
- 2026-08-10 8-K